"The Part D Enhanced Medication Therapy Management (Enhanced MTM) model will assess whether providing selected Medicare Prescription Drug Plans (PDPs) with additional incentives and flexibilities to design and implement innovative programs will better achieve the overall goals for MTM programs, including: improving compliance with medication protocols, including high-cost drugs, ensuring that beneficiaries get the medications they need, and they are used properly; reducing medication-related problems, such as duplicative or harmful prescription drugs, or suboptimal treatments; increasing patients' knowledge of their medications to better achieve their or their prescribers' goals of therapy; and improving communication among prescribers, pharmacists, caregivers and patients."